Phase III Trials of Standard Chemotherapy with or without Bevacizumab for Ovarian Cancer: A Meta-Analysis

Open Access

Peer-reviewed

Research Article

Mingyi Zhou ,

Contributed equally to this work with: Mingyi Zhou, Ping Yu

Affiliations Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China, Seven-Year Academic Program for Master, China Medical University, Shenyang, China
⨯
Ping Yu ,

Contributed equally to this work with: Mingyi Zhou, Ping Yu

Affiliation Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China
⨯
Xiujuan Qu,

Affiliation Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China
⨯
Yunpeng Liu,

Affiliation Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China
⨯
Jingdong Zhang

* E-mail: zhangjd0228@hotmail.com

Affiliation Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China
⨯

Reader Comments (0)

Chemotherapy
Is the Subject Area "Chemotherapy" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
Cancer risk factors
Is the Subject Area "Cancer risk factors" applicable to this article?

Thanks for your feedback.
Cancer chemotherapy
Is the Subject Area "Cancer chemotherapy" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Surgical and invasive medical procedures
Is the Subject Area "Surgical and invasive medical procedures" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.
Cancer detection and diagnosis
Is the Subject Area "Cancer detection and diagnosis" applicable to this article?

Thanks for your feedback.